Discover J&J
Medicines & therapies
Medical devices & technology
Discover J&J
Medicines & therapies
Medical devices & technology
Careers
Media
Contact
locationPlaceholder
Choose your country or region
Global
Global
English
North America
North America (Regional)
English
Canada
English
Français
United States
English
Asia Pacific
Asia Pacific (Regional)
English
Australia
English
China
中文
Hong Kong
English
中文
Japan
日本
Korea
한국어
New Zealand
English
Europe, Middle East & Africa (EMEA)
EMEA (Regional)
English
Middle East - Africa
الشرق الأوسط و أفريقيا (عربي)
Austria
Deutsch
Belgium
English
Français
Nederlands
Bulgaria
БЪЛГАРСКИ
Croatia
Hrvatski
Czech Republic
čeština
Denmark
Dansk
Estonia
English
Finland
Suomi
France
Français
Germany
Deutsch
Greece
ΕΛΛΗΝΙΚΑ
Hungary
Magyar
Ireland
English
Israel
עברית
Italy
Italiano
Latvia
English
Lithuania
English
Netherlands
Nederlands
Norway
Norsk
Poland
Polski
Portugal
Português
Romania
Română
Russia
Pусский
Serbia
Srpski
Slovakia
Slovenčina
Slovenia
Slovenščina
South Africa
English
Spain
Español
Switzerland
Français
Deutsch
Sweden
Svensk
Turkey
Türkçe
United Kingdom
English
Latin America
Latin America (Regional)
Español
Argentina
Español
Bolivia
Español
Brazil
Português
Central America and the Caribbean
Español
Chile
Español
Colombia
Español
Ecuador
Español
Mexico
Español
Paraguay
Español
Peru
Español
Uruguay
Español
Healthcare areas
Oncology
Immunology
Neuroscience
Cardiopulmonary
Products
Clinical trials
Pipeline
Patient resources
Innovative Medicine
healthcare areas
Menu
Healthcare areas
Oncology
Immunology
Neuroscience
Cardiopulmonary
Products
Clinical trials
Pipeline
Patient resources
Careers
Media
Contact
Show Search
Search Query
Clear
Submit Search
Dictate search request
Listening...
Search Results
No Results
See all results
Sorry, I don't understand. Please try again
Search Results
Search Query
Submit Search
Listening...
Dates
All (1125)
Last 7 days (1)
2024 (101)
2023 (76)
2022 (58)
2021 (67)
2020 (42)
2019 (68)
2018 (77)
2017 (80)
2016 (64)
Types
All (1125)
Article (56)
Page (7)
Press Release (1062)
There are 1,125 results that match your search.
Filters
Dates
All (1125)
Last 7 days (1)
2024 (101)
2023 (76)
2022 (58)
2021 (67)
2020 (42)
2019 (68)
2018 (77)
2017 (80)
2016 (64)
Types
All (1125)
Article (56)
Page (7)
Press Release (1062)
Relevance
Relevance
Newest
Oldest
Innovative Medicine
October 31, 2011
Supplemental New Drug Application Submitted To FDA For NUCYNTA® ER (Tapentadol) Extended-Release Tablets For Diabetic Peripheral Neuropathic Pain
Read more
Innovative Medicine
October 21, 2011
STELARA® (Ustekinumab) Is Effective, Well-Tolerated And Improves Quality Of Life In Patients With Moderate To Severe Plaque Psoriasis Inadequately Responsive To Methotrexate[1,2]
NEW DATA PRESENTED AT EADV
Read more
Innovative Medicine
October 21, 2011
FDA Approves Label Update for PREZISTA® to Include 192-Week Data in HIV-1-Infected Adult Patients Starting Treatment
Read more
Innovative Medicine
October 5, 2011
Scios Inc. Announces Agreement with Department of Justice Regarding NATRECOR®
Read more
Innovative Medicine
September 29, 2011
Casey Abrams Announces Finalists in National Inflammatory Bowel Disease Awareness Campaign and Calls on America to Vote
After opening up about his own battle with Ulcerative Colitis, season 10 American Idol contestant Casey Abrams pledges to shave his signature beard if 1,500 people join the cause at IBDIcons.com
Read more
Innovative Medicine
September 28, 2011
STELARA® Awarded 2011 Prix Galien USA in Best Biotechnology Product Category
Read more
Innovative Medicine
September 23, 2011
EDURANT® (Rilpivirine) Receives Positive Opinion from the Committee for Medicinal Products for Human Use (CHMP) For Use in Treatment-Naïve Adults with HIV-1
Third HIV medication submitted by Tibotec
Read more
Innovative Medicine
September 23, 2011
REMICADE® Receives FDA Approval as First Biologic Treatment for Pediatric Ulcerative Colitis
Approval Expands Access to REMICADE for Children Living with Ulcerative Colitis
Read more
Innovative Medicine
September 22, 2011
Health Canada Approves Expanded Indication For SIMPONI®* To Include Inhibition Of Structural Damage In The Treatment Of Moderately To Severely Active Rheumatoid Arthritis
SIMPONI® Indication Also Expanded To Include Improvement In Physical Function
Read more
Innovative Medicine
September 20, 2011
INCIVO® (Telaprevir) Approved In Europe Offering Higher Cure Rates For Genotype-1 Chronic Hepatitis C Compared To Standard Treatment
New treatment options increase chance of a cure
Read more
108 of 113